News - January 1, 2021
TRANSFORM: Multi-stakeholder approach to gene and cell therapies
Following a successful launch event, the TRANSFORM MEP Interest Group, a multi-stakeholder alliance of Members of European Parliament, patient groups, academia and industry, published two important documents to lay the foundations of an open discussion on key priorities for gene and cell therapies, namely a Call to Action and a Consensus Statement.
The two documents put forward concrete recommendations on the necessary adaptations of our health systems to the growing importance of gene and cell therapies, with the objective to start open dialogues around these transformative therapies at the EU level, including in the framework of the European Commission proposal for a Pharmaceutical Strategy.
For more information on the work of TRANSFORM and the work of EUCOPE on ATMPs, please contact Laurent Louette (email@example.com).